English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Dear sir,The TNF-α inhibitor Infliximab (IFX) has the potential to induce immunogenicity. Episodic treatment with IFX increases the risk of infusion reactions as compared to scheduled treatment.1 We present a case of serum sickness-like symptoms in a pregnant woman with ulcerative colitis (UC) following IFX reintroduction.Debut of ulcerative pancolitis in a 26 year old woman was initially treated with systemic steroids. Remission was attained with IFX induction series with four infusions (5 mg/kg) followed by maintenance treatment with 5-aminosalicylic acid (5-ASA) 3200 mg daily.Flare in UC occurred around the time of conception 18 months …

Serum sickness-like reaction due to Infliximab reintroduction during pregnancy